Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccines

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Somatic mutations in tumors generate neoepitopes, which are targets for T cell-mediated tumor immunity.
• The precise characteristics of efficacious neoepitopes that mediate in vivo tumor control are not well understood.
• Neoepitopes present unique challenges due to their similarity to self-epitopes, complicating immune response regulation.

Purpose of the Study:

• To critically discuss emergent questions in neoepitope biology and clinical applications.
• To propose a mechanistic and testable framework for understanding neoepitope complexity and translational potential.

Main Methods:

• Review and critical discussion of existing studies in mice and clinical trials.
• Analysis of neoepitope recognition through the lens of negative thymic selection.
• Development of a conceptual framework for neoepitope research.

Main Results:

• Neoepitopes exhibit unique immunological properties distinct from non-self antigens.
• Immune responses to neoepitopes are regulated, in part, similarly to self-antigens.
• A framework is proposed to address the complexity and translational potential of neoantigens.

Conclusions:

• Further research is needed to elucidate the rules governing effective neoepitope recognition and T cell activation.
• Understanding neoepitope regulation is crucial for developing effective cancer immunotherapies.
• The proposed framework aims to guide future investigations into neoepitope-based cancer treatments.